November 19th 2024
Adam J. James, PharmD, joined Drug Topics to discuss his career journey as a chain pharmacist.
November 18th 2024
Drug Topics sat down with Adam J. James, PharmD, to discuss his journey from chain pharmacist to innovation leader at Rite Aid."
October 2nd 2023
September 20th 2023
Suicides among health care professionals are estimated to occur at a higher rate than in the general public.
August 13th 2023
What can pharmacists do to bring innovative care models into their stores to serve their communities?
USP Postponing Chapters 795, 797, and 825
Several pharmacy groups appealed guideline revisions.
FDA Approves Jynneos for Smallpox and Monkeypox in Adults
Will be part of the U.S.’s public health emergency medical supplies and pharmaceuticals.
FDA Urged to Expedite Ranitidine Recalls
Online pharmacy that discovered the impurity discontinues sales.
Investigational Guillain-Barré Syndrome Treatment Granted FDA Fast Track Designation
Monoclonal antibody for autoimmune and neurodegenerative disorders.
The Growing Problem of Pharmacy Deserts
An estimated 100 million Americans lack good access to pharmacies.
What is a Pharmacy Desert?
Caused by lower income, insurance status, higher prices, poor transportation, long distances.
New Semaglutide Dosage Forms Approved by FDA
Now approved in 7mg and 14 mg tablets.
Patient Services are Crucial to the Economics of Pharmacy
Layoffs highlight increasing jobs problem.
At a Glance: Asthma Biologics
Obinutuzumab Receives Breakthrough Therapy Designation from FDA
Monoclonal antibody shows potential for lupus nephritis treatment.
Antimicrobial Stewardship: Protecting Global Health
Programs shown to improve patient outcomes, reduce antibiotic resistance, and decrease healthcare costs.
Vaccinations Are Increasingly Important as Hepatitis A Epidemic Grows
23,600 cases across 29 states since 2016.
Fear Motivates Vaccinations, New Study Finds
Fear, one's faith in the government, and likelihood of exposure are leading factors.
Optimism for AI in Cancer Care
Oncologists recognize the potential of artificial intelligence (AI) in improving the quality of care and patient outcomes according to new research.
New Drug Review: Pretomanid for Highly Drug Resistant Tuberculosis
Indicated as part of a three-drug oral combination.
Oncology Market Remains Robust, Says Report
The 2018 oncology drug market had a record number of new treatments and continued a trend of growth.
Tenapanor Approved for Adults with IBS-C
NHE3 inhibitor administered as 50 mg oral tablets.
Asthma Care Complications
New medications and treatment guidelines
FDA Warns of NDMA Traces in Ranitidine Products
Patients are still allowed to take medicines as prescribed.
DEA to Slash Opioid Production
Fentanyl, oxymorphone, and hydrocodone face greatest cuts.
Senate Finance Committee Wants Trump Action on DIR Fees
Eight pharmacy groups lauded a letter urging the Trump administration to reform direct and indirect remuneration (DIR) fees.
MS Drugs in the Pipeline
Current phase 3 studies investigative novel, preventative approaches.
FDA Grants Tepotinib Breakthrough Therapy Designation
Investigational oral MET kinase inhibitor from Merck.
CDC, AAP Release New Childhood Flu Vaccine Recommendations
The age indication for some influenza vaccines has been expanded.
Generics and Biosimilars Facing Formulary Difficulties
New changes are making it more difficult for generics and biosimilars to compete on formularies.
Clinical Services Result in Staffing Evolutions
Technicians, clerks, even front-end cashiers are taking on new responsibilities.
Support Staff Training Resources
FDA Approves New Generic for Rare HT-1 Disorder
Oral supplements for metabolic disorder.
Nintedanib Approved for Rare Lung Disease
Oral kinase inhibitor for SSc-ILD.
Decitabine and Fosaprepitant Generics Approved by FDA
First generic specialty injections approved for Novadoz Pharmaceuticals.